Arena Pharmaceuticals Gets FDA's OK For Obesity Drug

2:15pm (EST) We always say plan your trades and trade your plan. Arena Pharmaceuticals (ARNA, $11.87, up $3.02) has opened for trading and we are seeing.(By Rich Bieglmeier) Arena Pharmaceuticals, Inc. (ARNA) obesity drug, now called Belviq (formerly known as lorcaserin) has been Okayed by an 18-4 vote. It is the first new obesity drug to hit the market in 13 years. The stock(HALTED). Written on June 27, 2012 by gem-x in Elliott Wave Intraday - 12:23 pm. http://finance.yahoo.com/news/arena-pharmaceuticals-confirms-fda-approval-171615365.html. 0

Read more ...